Abstract

“Indigenous vaccine” developed from native “Indian Bison Type” strain (“S5”) of Mycobacterium avium subspecies paratuberculosis (MAP) of “goat origin” was first time evaluated in a sheep flock of Bharat Merino breed located in Mannavanur town of Tamil Nadu in South India. Therapeutic efficacy of the vaccine was evaluated for 3 years between 2008 and 2010, on the basis of improvements in productivity (body weights, reproductive efficiency and survivability), physical condition, clinical symptoms (weakness, diarrhea, wool quality), immune response (sero-conversion) and infection load in feces (shedding). After immunization of the flock in 2008, the successive progenies of 112 and 53 lambs born in 2009 and 2010, respectively were vaccinated. Whereas, 40 lambs born to control animals were kept as unvaccinated controls. Though gain in body weights in vaccinated versus controls were not significant in 2008, growth rates were distinctly superior in Ist and IInd generations of vaccinated lambs. Reproductive performance (tupping percent) and survivability of lambs and adult sheep improved significantly. There was overall reduction in yearly morbidity (diarrhea) and mortality rates of the flock in post vaccination years. Shedding of MAP in feces was reduced in vaccinated sheep by 6.2%, 14.3% and 27.3% in 2008, 2009 and 2010 respectively, whereas shedding increased in the control sheep. Seromonitoring of the animals by “indigenous ELISA kit” showed enhanced “flock immunity” in successive generations. “Indigenous vaccine” reduced clinical disease and shedding and improved immunity and productivity of Bharat Merino flock, endemic for Johne’s disease.

Highlights

  • Paratuberculosis or Johne’s disease (JD), caused by Mycobacterium avium subspecies paratuberculosis (MAP), is the most important disease of domestic ruminants and is responsible for substantial economic losses to the livestock industry world-over [1,2,3]

  • “Indigenous vaccine” developed from native “Indian Bison Type” strain (“S5”) of Mycobacterium avium subspecies paratuberculosis (MAP) of “goat origin” was first time evaluated in a sheep flock of Bharat Merino breed located in Mannavanur town of Tamil Nadu in South India

  • Indigenous ELISA test uses semipurified soluble protoplasmic antigen (PPA) prepared from the native isolates of MAP (“S5”) recovered from a terminal case of JD in a Jamunapari goat (CIRG) and has since been characterized as “Indian Bison type” [25], OD values were transformed to S/P ratio [31] and sheep in strong positive and positive category were considered as positive for MAP infection and as sero-converts

Read more

Summary

Introduction

Paratuberculosis or Johne’s disease (JD), caused by Mycobacterium avium subspecies paratuberculosis (MAP), is the most important disease of domestic ruminants and is responsible for substantial economic losses to the livestock industry world-over [1,2,3]. Evaluation of “Indigenous Vaccine” Developed Using “Indian Bison Type” Genotype of Mycobacterium Avium subspecies 53 Paratuberculosis Strain “S5” of Goat Origin in a Sheep Flock Endemic for Johne’s Disease: A Three Years Trial in India low to very high prevalence of JD in some of the native sheep flocks. Strain “S5” of MAP has since been characterized as “Indian Bison Type”—a new biotype of MAP not reported so far in the literature [25] Evaluation of this “indigenous vaccine” showed high efficacy both as “preventive and therapeutic” vaccine in herds endemic for Johne’s disease [23,24]. Production performance, status of clinical disease, concentration (+4 to +1) of MAP bacilli/gm of feces (shedders), immunological parameters between vaccinated and nonvaccinated control groups of Bharat Merino sheep located down south in the hills of Nilgiris, and Mannavanur block of Tamil Nadu was compared

Experimental Animals and Monitoring Parameters
Vaccination
Live Body Weights
Shedding of MAP in Feces
MAP Bacteraemia and Genotyping
Vaccine Mediated Sero-Conversion
Results and Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call